CFG
CELG

Cambridge Financial Group’s Celgene Corp CELG Stock Holding History

Cambridge Financial Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-55,616
Closed -$6.02M – 36
2015
Q3 		$6.02M Sell
55,616
-2,467
-4% -$306K 3.6% 8
2015
Q2 		$6.72M Sell
58,083
-4,365
-7% -$499K 3.58% 7
2015
Q1 		$7.2M Buy
62,448
+55,918
+856% +$6.68M 3.56% 8
2014
Q4 		$730K Sell
6,530
-59,790
-90% -$6.31M 3.55% 9
2014
Q3 		$6.29M Buy
+66,320
New +$5.99M 3.14% 20

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Cambridge Financial Group's CELG Position: Q4 2015 in Review

Cambridge Financial Group sold out of Celgene Corp (CELG) in Q4 2015, closing a stake of 55,616 shares — an estimated $6.02M sold.

Cambridge Financial Group first reported a position in CELG in Q3 2014 and held it in 5 quarters. The position peaked at $7.2M in Q1 2015. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

  • Cambridge Financial Group reported no remaining Celgene Corp position as of Q4 2015 after selling out during the quarter.
  • Cambridge Financial Group sold 55,616 Celgene Corp shares in Q4 2015, an estimated $6.02M.
  • Cambridge Financial Group first reported a position in Celgene Corp in Q3 2014 and held it in 5 quarters.
  • Cambridge Financial Group's Celgene Corp position peaked at $7.2M in Q1 2015.
  • 1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Cambridge Financial Group's 13F filing for Q4 2015, filed 17 Feb 2016.